Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Imunon Inc (IMNN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Imunon's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.1400 -0.2300    -16.79%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
1.4499
+0.3099
+27.1842%
19:59:32 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 149,109
  • Bid/Ask: 1.0800 / 1.4500
  • Day's Range: 1.1200 - 1.3600
Imunon 1.1400 -0.2300 -16.79%

Imunon Inc Company Profile

 
Get an in-depth profile of Imunon Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

29

Equity Type

ORD

Imunon, Inc. is a clinical-stage biotechnology company. It is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. It has two platform technologies: TheraPlas platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies, and the PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. Its lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer. IMNN-001 works by instructing the body to produce cancer fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, it is conducting preclinical studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus to validate its PLACCINE platform. Its platform technologies are based on the delivery of nucleic acids with synthetic delivery systems that are independent of viral vectors or devices.

Contact Information

Address 997 Lenox Drive Suite 100
Lawrenceville, 08648
United States
Phone 609 896 9100
Fax 609 896 2200

Top Executives

Name Age Since Title
Michael H. Tardugno 71 2007 Executive Chairman
Donald P. Braun 74 2015 Independent Director
Wafik El-Deiry - - Member of Advisory Board
Frederick J. Fritz 73 2011 Independent Director
Mark W. Dewhirst - - Member of Advisory Board
Michael E. Weinblatt - - Member of Advisory Board
David Cheresh - - Member of Advisory Board
Jerry Glickson - - Member of Advisory Board
Britt A. Glaunsinger - 2021 Member of the Advisory Board
Luke D. Handke - 2021 Member of Vaccine Advisory Board
Patrick Ott - 2023 Member of Scientific Advisory Board
Peter Corry - - Member of Advisory Board
Stacy R. Lindborg 54 2021 Independent Director
Xinzhen Yang - 2021 Member of the Advisory Board
Christine A. Pellizzari 56 2021 Independent Director
Dan H. Barouch - 2021 Member of Vaccine Advisory Board
Sachet A. Shukla - 2023 Member of Scientific Advisory Board
James E. Dentzer 57 2022 Independent Director
John W. Shiver - - Member of Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IMNN Comments

Write your thoughts about Imunon Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mika Salminen
Mika Salminen Mar 28, 2024 11:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
up up up
Mika Salminen
Mika Salminen Feb 28, 2024 12:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what now ?
Mika Salminen
Mika Salminen Feb 28, 2024 12:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what now ?
Willie Scott
Willie Scott Mar 01, 2022 10:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
YEAH... this is awesome
José Silva
José Silva Feb 28, 2022 2:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats new? All this because of the sale? What news do you have on the reverse stock split?
antonis theofilou
antonis theofilou Feb 01, 2022 5:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Resurrection of the dead 🙏
José Silva
José Silva Jan 21, 2022 1:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any news on this? Bankrupcy ahead?
damian del
mudlog79 Jan 18, 2022 4:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is bad.. bleeding here
José Silva
José Silva Jan 18, 2022 4:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Related to the stock offering?
Ziyad Ghanim
Ziyad Ghanim Jan 13, 2022 2:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They are selling it less than book value 😠
José Silva
José Silva Jan 13, 2022 2:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why?
Ziyad Ghanim
Ziyad Ghanim Jan 13, 2022 2:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No idea
damian del
mudlog79 Jan 13, 2022 12:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow.. bloodbath
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email